Filing Flows

Filing Flows › Comparisons › HAE vs TNDM

Haemonetics vs Tandem Diabetes Care: HAE and TNDM compared

Haemonetics is the larger company: $358M of revenue in its latest quarter (Q2 FY27) against $284M for Tandem Diabetes Care (Q3 2026). Tandem Diabetes Care is growing faster (+14% against +9% a year earlier). Haemonetics is more profitable, with an operating margin of 21.0% against -0.8%.

Haemonetics vs Tandem Diabetes Care, latest quarterHaemonetics vs Tandem Diabetes Care, latest quarterHaemonetics (HAE)Tandem Diabetes Care (TNDM)Revenue$358M$284MRevenue growth, Y/Y+9%+14%Operating margin21.0%-0.8%Net margin12.9%-2.5%

Where the money goes: HAE and TNDM

Haemonetics (HAE) · Q2 FY27

Haemonetics, Q2 FY27: revenue $358M (+9% year over year), operating margin 21.0%, net earnings $46.3M, operating cash flow $128M. The chart follows the revenue to costs, profit and cash.

Tandem Diabetes Care (TNDM) · Q3 2026

Tandem Diabetes Care, Q3 2026: revenue $284M (+14% year over year), operating margin -0.8%, net loss $7.1M, operating cash flow −$819K. The chart follows the revenue to costs, profit and cash.

Haemonetics revenue by segment, Q2 FY27Haemonetics revenue by segment, Q2 FY27Apheresis$205MMedSurg$153M
Tandem Diabetes Care revenue by segment, Q3 2026Tandem Diabetes Care revenue by segment, Q3 2026Supplies and other$169MPump$115M
Haemonetics (HAE)Tandem Diabetes Care (TNDM)
Latest quarterQ2 FY27Q3 2026
Revenue$358M$284M
Revenue growth, Y/Y+9%+14%
Gross margin61.7%—
Operating margin21.0%-0.8%
Net earnings$46.3M−$7.1M
Net margin12.9%-2.5%
Operating cash flow$128M−$819K
Free cash flow$113M—
Market value$5.6B$1.2B
P/E53.6×—
Analysts’ mean target$124.50$27.57

Where the revenue comes from

Haemonetics

Tandem Diabetes Care

Questions

Which is bigger, Haemonetics or Tandem Diabetes Care?

Haemonetics is the larger company: $358M of revenue in its latest quarter (Q2 FY27) against $284M for Tandem Diabetes Care (Q3 2026).

Is Haemonetics or Tandem Diabetes Care growing faster?

Tandem Diabetes Care is growing faster (+14% against +9% a year earlier).

Which is more profitable, Haemonetics or Tandem Diabetes Care?

Haemonetics is more profitable, with an operating margin of 21.0% against -0.8%.

More: Haemonetics earnings · how Haemonetics makes money · Tandem Diabetes Care earnings · how Tandem Diabetes Care makes money

From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Nov 5, 2026). Fiscal quarters can end on different dates. Not investment advice.